# Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster® in COPD

> **NCT01917331** · PHASE3 · COMPLETED · sponsor: **Chiesi Farmaceutici S.p.A.** · enrollment: 1368 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Beclometasone/Formoterol/Glycopyrrolate
- **DRUG:** Beclometasone/Formoterol

## Key facts

- **NCT ID:** NCT01917331
- **Lead sponsor:** Chiesi Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2016-01
- **Final completion:** 2016-03
- **Target enrollment:** 1368 (ACTUAL)
- **Last updated:** 2021-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01917331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01917331, "Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster® in COPD". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01917331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*